A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice.
Shalinsky, D R
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. [electronic resource] - Cancer research Jan 1997 - 162-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Animals
Antineoplastic Agents--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Drug Screening Assays, Antitumor
Humans
Mice
Mice, Nude
Mouth Neoplasms--drug therapy
Receptors, Retinoic Acid--agonists
Retinoids--therapeutic use
Transplantation, Heterologous
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. [electronic resource] - Cancer research Jan 1997 - 162-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Animals
Antineoplastic Agents--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Drug Screening Assays, Antitumor
Humans
Mice
Mice, Nude
Mouth Neoplasms--drug therapy
Receptors, Retinoic Acid--agonists
Retinoids--therapeutic use
Transplantation, Heterologous